Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

Women with PCOS have higher levels of DHEA, IL-6, and TNF-α.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.